FDA Inspection
Exelixis, Inc.Exelixis, Inc. – FDA Inspection, May 5, 2026
Record Details
This FDA Inspection record concerns Exelixis, Inc., with an inspection on May 5, 2026, issued by the San Francisco District Office, covering human drugs.
View Company Profile
ID · d1b3bb11-6beb-4455-89a0-921c99e321ad
Inspection Facts
- Inspection number
- 1319178
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 312.50General responsibilities of sponsors
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Exelixis, Inc.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| March 27, 2018 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| September 27, 2012 | OAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Exelixis, Inc.
- FDA Inspection 1049904 - 2018-03-27
- FDA Inspection 802660 - 2012-09-27
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.